- As per the recommendation of the expert committee on Covid-19 of the CSDCO DCGI's given approval for emergency use in children.
- The SEC discussed the EUA application of SII and recommended granting emergency use authorization for Covovax for children aged 7 to 11 years.
- With this approval, it is almost the last mile covered in the mission of the COVID-19 vaccine for all.
- Earlier in December 2021, the government had cleared Covovax for restricted use in an emergency in adults and the 12 to 17 years age group.
- India began inoculating children aged 12-14 years in the past two months.
- Apart from that, they have also begun administering precautionary doses of vaccines to healthcare and frontline workers and those aged 60 and above.
Question:
Q.1 DGCI has approved which of the following Vaccine for children between the age group of 7 and 12 years?a. Corbevax
b. Covovax
c. Covaxin
d. Sinopharm
